Strategy to Avoid Excessive Oxygen for Critically Ill Trauma Patients

ClinicalTrials.gov ID: NCT04534959

Public ClinicalTrials.gov record NCT04534959. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 22, 2026, 2:42 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Strategy to Avoid Excessive Oxygen for Critically Ill Trauma Patients (SAVE-O2)

Study identification

NCT ID: NCT04534959
Recruitment status: Active, not recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: University of Colorado, Denver; Other
Enrollment: 6,000 participants

Conditions and interventions

Conditions

Interventions

Targeting Normoxemia (SpO2 90-96%; PaO2 60-100 mmHg) Other

Other

Eligibility (public fields only)

Age range: 18 Years to 120 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Oct 14, 2020
Primary completion: Nov 14, 2022
Completion: Jun 29, 2025
Last update posted: Apr 1, 2025

2020 – 2025

United States locations

U.S. sites: 8
U.S. states: 7
U.S. cities: 8

Facility	City	State	ZIP	Site status
University of Alabama-Birmingham Medical Center	Birmingham	Alabama	35294	—
Denver Health	Denver	Colorado	80204	—
University of Cincinnati Medical Center	Cincinnati	Ohio	45219	—
Oregon Health and Sciences University	Portland	Oregon	97239	—
University of Pittsburgh Medical Center	Pittsburgh	Pennsylvania	15224	—
Vanderbilt University Medical Center	Nashville	Tennessee	37232	—
Brooke Army Medical Center	Fort Sam Houston	Texas	78234	—
The University of Texas Health Science Center at Houston	Houston	Texas	77030	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT04534959, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 1, 2025 · Synced Jul 22, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04534959 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →